Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
The Board of Directors of Pharmaniaga Berhad ("Company") wishes to announce that all Resolutions as set out in the Notice of the Extraordinary General Meeting ("EGM") of the Company dated 19 February 2025 and Amended Notice of EGM dated 27 February 2025 were duly passed by the shareholders at the EGM of the Company today. All the Resolutions were voted by poll and the results of the poll were validated by Quantegic Services Sdn. Bhd., the independent scrutineer appointed by the Company.
Please refer to the attachment for the poll results.
This announcement is dated 20 March 2025.
Voting Results
1. Ordinary Resolution 1
Description
Proposed renounceable rights issue of new ordinary shares in the Company ("Rights Shares") to raise gross proceeds of up to RM353.5 million on an entitlement date to be determined and announced later ("Proposed Rights Issue")
Shareholder’s Action
For Voting
Voted
For
Against
No. of Shareholders
157
14
No. of Shares
795,434,198
677,440
% of Voted Shares
99.9149
0.0851
Result
Accepted
2. Ordinary Resolution 2
Description
Proposed private placement of new Pharmaniaga shares to third party investor(s) to be identified later at an issue price to be determined later to raise gross proceeds of up to RM300.0 million, with a minimum of RM215.0 million ("Proposed Private Placement")
Shareholder’s Action
For Voting
Voted
For
Against
No. of Shareholders
158
13
No. of Shares
795,527,938
583,700
% of Voted Shares
99.9267
0.0733
Result
Accepted
3. Special Resolution 1
Description
Proposed capital reduction of the issued share capital of the Company by the cancellation of RM520.0 million issued share capital which is lost and/or unrepresented by available assets pursuant to Section 117 of the Companies Act 2016 ("Act") ("Proposed Capital Reduction")